Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

Isis surprised by disappointing results in Crohn's disease study of ISIS-2302

Dec. 22, 1999

Pivotal studies begin for Emitasol

Dec. 22, 1999

SK-951 demonstrates advantages over cisapride in models of impaired gastric emptying

Dec. 21, 1999

ViroPharma and Wyeth-Ayerst form alliance to develop HCV drugs

Dec. 16, 1999

Infliximab now available in U.K. through Centocor licensee

Dec. 16, 1999

InKine initiates phase II multicenter trial for IBD treatment

Dec. 15, 1999

Role for antioxidant in the treatment of ulcers: experimental results presented at Indian congress

Dec. 15, 1999

Nippon Chemiphar withdraws Leminon 80 application for approval in Japan

Dec. 15, 1999

Medivir investigates new treatments for hepatitis B

Dec. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...